Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats

Expert Opinion on Biological Therapy

Volumn 13, Issue 7, 2013, Pages 959-972

  Najafi, R ^a,b   Sharifi, Ali M ^a,b,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cell therapy; Deferoxamine; Hypoxia inducible factor 1 ; Mesenchymal stem cell homing; Type 1 diabetes

Indexed keywords

2 METHOXYESTRADIOL; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR4; DEFEROXAMINE; GELATIN; GELATINASE A; GELATINASE B; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL HOMING; CELL MIGRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DEFEROXAMINE; DIABETES MELLITUS, EXPERIMENTAL; FLOW CYTOMETRY; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIDEROPHORES; SIGNAL TRANSDUCTION; TRANSPLANTATION CONDITIONING;

RATTUS;

EID: 84878913675     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2013.782390     Document Type: Article

References (61)

1. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004;279:42351-4
2. Dean PG, Kudva YC, Stegall MD. Long-term benefits of pancreas transplantation. Curr opin org Transplant 2008;13:85-90
3. Nanji SA, Shapiro A. Advances in pancreatic islet transplantation in humans. Diabetes Obes Metab 2006;8:15-25
4. Meloche RM. Transplantation for the treatment of type 1 diabetes. World J Gastroenterol 2007;13:6347-55
5. Yamaoka T. Regeneration therapy of pancreatic [beta] cells: towards a cure for diabetes? Biochem Biophysl Res Commun 2002;296:1039-43
6. Abdi R, Fiorina P, Adra CN, et al. Immunomodulation by mesenchymal stem cells. Diabetes 2008;57:1759-67
7. Steingen C, Brenig F, Baumgartner L, et al. Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. J Mol Cell Cardiol 2008;44:1072-84
8. Chen FM, Wu LA, Zhang M, et al. Homing of endogenous stem/progenitor cells for in situ tissue regeneration: Promises, strategies, and translational perspectives. Biomaterials 2011;32:3189-209
9. Wagner J, Kean T, Young R, et al. Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol 2009;20:531-6
10. Li G, Zhang X, Wang H, et al. Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: implication in the migration. Proteomics 2009;9:20-30
11. Yagi H, Soto-Gutierrez A, Parekkadan B, et al. Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant 2010;19:667-79
12. Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol cell Cardiol 2008;45:514-22
13. Van Linthout S, Stamm C, Schultheiss HP. Mesenchymal stem cells and inflammatory cardiomyopathy: cardiac homing and beyond. Cardiol Res Pract 2011;2011:8
14. Shi M, Li J, Liao L, et al. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica 2007;92:897-904
15. Belema-Bedada F, Uchida S, Martire A, et al. Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2. Cell Stem Cell 2008;2:566-75
16. De Becker A, Van Hummelen P, Bakkus M, et al. Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 2007;92:440-9
17. Ikeda Y, Tajima S, Yoshida S, et al. Deferoxamine promotes angiogenesis via the activation of vascular endothelial cell function. Atherosclerosis 2011;215:339-47
18. Thangarajah H, Yao D, Chang EI, et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Nat Acad Sci 2009;106:13505-10
19. Chu K, Jung KH, Kim SJ, et al. Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1alpha stabilization in the host brain. Brain Res 2008;1207:182-92
20. Cioffi CL, Qin Liu X, Kosinski PA, et al. Differential regulation of HIF-1 [alpha] prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells. Biochem Biophys Res Commun 2003;303:947-53
21. Semenza GL. Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia inducible factor 1. Exp Physiol 2006;91:803-6
22. Ratajczak MZ, Reca R, Wysoczynski M, et al. Modulation of the SDF-1-CXCR4 axis by the third complement component (C3)- implications for trafficking of CXCR4+ stem cells. Exp Hematol 2006;34:986-95
23. Chan DA, SP, Denko NC, Giaccia AJ. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J Biol Chem 2002;277:40112-17
24. Cheng XW, Kuzuya M, Kim W, et al. Exercise training stimulates ischemia-induced neovascularization via phosphatidylinositol 3-kinase/Aktdependent hypoxia-induced factor-1alpha reactivation in mice of advanced age. Circulation 2010;122:707-16
25. Westenbrink BD, Ruifrok WPT, Voors AA, et al. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. Cardiovasc Res 2010;87:30-9
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5
28. Abeeleh MA, Ismail ZB, Alzaben KR, et al. Induction of diabetes mellitus in rats using intraperitoneal streptozotocin: a comparison between 2 strains of rats. Eur J Sci Res 2009;32:398-402
29. Adewale O, Oloyede O. Hypoglycemic activity of aqueous extract of the bark of Bridelia ferruginea in normal and alloxan-induced diabetic rats. Prime Res Biotechnol 2012;2:53-6
30. Sharifi AM, Mottaghi S. Finasteride as a potential tool to improve Mesenchymal stem cell transplantation for myocardial infarction. Med Hypotheses 2012;78:465-7
31. Mottaghi S, Larijani B. Atorvastatin: an efficient step forward in mesenchymal stem cell therapy of diabetic retinopathy. Cytotherapy 2012;S1465-3249(12):00030-8
32. Martinez Romero R, Martinez Lara E, Aguilar Quesada R, et al. PARP 1 modulates deferoxamine induced HIF 1alpha accumulation through the regulation of nitric oxide and oxidative stress. J Cell Biochem 2008;104:2248-60
33. Nguyen M, Pouvreau S, El Hajjaji F, et al. Desferrioxamine enhances hypoxic ventilatory response and induces tyrosine hydroxylase gene expression in the rat brainstem in vivo. J Neurosc Res 2007;85:1119-25
34. Park K, Chung K, Sung S, et al. Protective effect of desferrioxamine during canine liver transplantation: significance of peritransplant liver biopsy. Transplant Proc 2003;35(1):117-19
35. Thangarajah H, Vial IN, Grogan RH, et al. HIF-1alpha dysfunction in diabetes. Cell Cycle 2010;9:75-9
36. El-Khatib AS, Moustafa AM, Abdel-Aziz AAH, et al. Effects of aminoguanidine and desferrioxamine on some vascular and biochemical changes associated with streptozotocin-induced hyperglycaemia in rats. Pharmacol Res. 2001;43:233-40
37. Langlois A, Bietiger W, Mandes K, et al. Overexpression of vascular endothelial growth factor in vitro using deferoxamine: a new drug to increase islet vascularization during transplantation. Elsevier, Transplantation Proceedings; 2008. p. 473-6
38. Vaithilingam V, Oberholzer J, Guillemin G, Tuch B. Beneficial effects of desferrioxamine on encapsulated human islets-in vitro and in vivo study. Am J Transplant 2010;10:1961-9
39. Huang H, He Z, Roberts LJ, Salahudeen AK. Deferoxamine reduces cold ischemic renal injury in a syngeneic kidney transplant model. Am J Transplant 2003;3:1531-7
40. Freret T, Valable S, Chazalviel L, et al. Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat. Eur J Neurosc 2006;23:1757-65
41. Werth N, Beerlage C, Rosenberger C, et al. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS One 2010;5:e11576
42. Shen X, Wan C, Ramaswamy G, et al. Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice. J Orthop Res 2009;27:1298-305
43. Milosevic J, Adler I, Manaenko A, et al. Non-hypoxic stabilization of hypoxia-inducible factor alpha (HIFalpha): relevance in neural progenitor/ stem cells. Neurotox Res 2009;15:367-80
44. Dai Y, Xu M, Wang Y, et al. HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol 2007;42:1036-44
45. Yamaji-Kegan K, Su Q, Angelini DJ, et al. Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. Am J Physiol Lung Cell Mol Physiol 2006;291:L1159-68
46. Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004;104:2224-34
47. Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002;30:973-81
48. Lolmede K. Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int J obesity 2003;27:1187-95
49. Jin H, Yamamoto N, Uchida K, et al. Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient L-amino acid-defined diet. Biochem Biophys Res Commun 2007;364:801-7
50. Munoz-Najar U, Neurath K, Vumbaca F, Claffey K. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene 2005;25:2379-92
51. Wong MM, Fish EN. Chemokines: Attractive mediators of the immune response. Semin Immunol 2003;15:5-14
52. Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 2008;28(11):1950-9
53. Belmadani A, Tran PB, Ren D, Miller RJ. Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J Neurosci 2006;26:3182-91
54. Xu F, Shi J, Yu B, et al. Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro. Oncol Rep 2010;23:1561-7
55. Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem cells 2009;28:585-96
56. Smart N, Riley PR. The stem cell movement. Circ Res 2008;102:1155-68
57. Schenk S, Mal N, Finan A, et al. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem cells 2007;25:245-51
58. Wang Y, Johnsen HE, Mortensen S, et al. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 2006;92:768-74
59. Pi X, Wu Y, Ferguson JE, et al. SDF-1alpha stimulates JNK3 activity via eNOS-dependent nitrosylation of MKP7 to enhance endothelial migration. Proce Nat Acad Sci 2009;106:5675-80
60. Li N, Lu X, Zhao X, et al. endothelial nitric oxide synthase promotes bone marrow stromal cell migration to the ischemic myocardium via upregulation of stromal cell derived factor 1alpha. Stem cells 2009;27:961-70
61. Shao H, Tan Y, Eton D, et al. Statin and stromal cell derived factor 1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels. Stem cells 2008;26:1376-84